Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stanford Medical Group (SMG) is the faculty practice of the Stanford University School of Medicine, serving as the clinical arm of the Stanford Medicine ecosystem. Established in 1981, the group provides high-complexity patient care across a broad spectrum of specialties, including oncology, cardiology, and neurosciences. SMG operates in close coordination with Stanford Health Care and Lucile Packard Children's Hospital, facilitating the translation of academic research into clinical therapies. The group is a global leader in precision health and regenerative medicine, managing an extensive pipeline of clinical trials and early-stage therapeutic programs through initiatives like the Center for Definitive and Curative Medicine (CDCM). By integrating advanced clinical practice with the university's research mission, Stanford Medical Group offers patients access to innovative treatments such as gene editing and novel cell-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stanford Medical Group.